Quotient Announces Extension of RapidFACT into Non-Oral Routes of Delivery
Quotient Clinical, part of Quotient Bioresearch (“Quotient”) today announced that three new pharma and biotech clients have selected its RapidFACT service to support the development of optimal drug products for pulmonary, transdermal, and ocular administration. This marks a key extension in the application of RapidFACT across a wide range of dosage forms and delivery routes.
RapidFACT (Rapid Formulation development And Clinical Testing) is underpinned by a Translational Pharmaceutics platform that integrates formulation development, “real-time” GMP product manufacturing, and clinical testing. Compared to conventional development processes, RapidFACT shortens development timelines, lowers costs, and also reduces the consumption of drug substance by up to 90%.
Mark Egerton, Managing Director of Quotient Clinical, said: “We are delighted that RapidFACT has been selected to support the development of these exciting new products. To date, RapidFACT has been deployed on over 30 programs that have focused on oral delivery or intranasal delivery. These new programs further demonstrate the broad utility of RapidFACT and our belief that it can be used to support the development of molecules for any route of delivery.”
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
